Open AccessExpert opinion. Spironolactone: a new twist on an old story
Author(s) -
Ya. A. Orlova,
Yu L Begrambekova,
A. G. Plisuk
Publication year - 2021
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2021.10.n1734
Subject(s) - spironolactone , expert opinion , context (archaeology) , mineralocorticoid receptor , covid-19 , medicine , computer science , intensive care medicine , biology , receptor , aldosterone , paleontology , disease , infectious disease (medical specialty)
The article presents recent data on possibilities of a broader use of mineralocorticoid receptor antagonists for existing indications and of expanding indications for the use of this pharmaceutical group in the context of the novel coronavirus infection COVID-19. The authors discussed prospects for expanded detection of aldosteronism using a new diagnostic approach, including an additional evaluation of blood pressure response to spironolactone.